Chat with us
Call us
08045813144
English
Spanish
French
German
Italian
Chinese (Simplified)
Japanese
Korean
Arabic
Portuguese
Send Inquiry
60mg Kabanat Cabazitaxel Injection
11000 INR/Piece
Product Details:
- Origin India
- Fermentation Smell Normal Smell
- Storage Instructions Cool & Dry Place
- Shelf Life 2 Years
- Click to View more
X
60mg Kabanat Cabazitaxel Injection Price And Quantity
- 1 Piece
- 11000 INR/Piece
60mg Kabanat Cabazitaxel Injection Product Specifications
- Cool & Dry Place
- Normal Smell
- 2 Years
- India
60mg Kabanat Cabazitaxel Injection Trade Information
- 1000 Piece Per Month
- 7 Days
Product Description
60mg Kabanat Cabazitaxel Injection is a chemotherapy drug used to treat prostate cancer that has spread to other parts of the body. It works by stopping the growth and spread of cancer cells. This injection is manufactured in India and has a shelf life of 2 years. It has a normal fermentation smell and should be stored in a cool and dry place. As a trusted exporter, supplier, and trader of pharmaceutical products, we ensure that our customers receive high-quality medicines at competitive prices.
FAQs of 60mg Kabanat Cabazitaxel Injection:
Q: What is 60mg Kabanat Cabazitaxel Injection used for?
A: It is used to treat prostate cancer that has spread to other parts of the body.Q: How does the injection work?
A: The injection works by stopping the growth and spread of cancer cells.Q: Where is the injection manufactured?
A: The injection is manufactured in India.Q: What is the shelf life of the injection?
A: The shelf life of the injection is 2 years.Q: How should the injection be stored?
A: The injection should be stored in a cool and dry place.Tell us about your requirement
Price:
Quantity
Select Unit
- 50
- 100
- 200
- 250
- 500
- 1000+
Additional detail
Mobile number
Email
Other Products in 'Anti Cancer Medicines' category
ARKON SOLUTIONS LLP
All Rights Reserved.(Terms of Use)
Developed and Managed by Infocom Network Private Limited.
Developed and Managed by Infocom Network Private Limited.
